洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 A pilot, open-label case series on the efficacy and safety of a synbiotic formula (HQP08) in preventing and managing chemotherapy-induced alopecia in cancer patients

【ChiCTR2500112638】A pilot, open-label case series on the efficacy and safety of a synbiotic formula (HQP08) in preventing and managing chemotherapy-induced alopecia in cancer patients

查看原文
立即下载
基本信息
登记号

ChiCTR2500112638

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-11-17

临床申请受理号

/

靶点

/

适应症

Chemotherapy-induced alopecia in cancer patients

试验通俗题目

A pilot, open-label case series on the efficacy and safety of a synbiotic formula (HQP08) in preventing and managing chemotherapy-induced alopecia in cancer patients

试验专业题目

A pilot, open-label case series on the efficacy and safety of a synbiotic formula (HQP08) in preventing and managing chemotherapy-induced alopecia in cancer patients

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

- To explore the efficacy and safety of a synbiotic formula (HQP08) in preventing and managing chemotherapy-induced alopecia in cancer patients - To study the compositional and functional changes in gut microbiome

试验分类
请登录查看
试验类型

病例对照研究

试验分期

其它

随机化

None

盲法

None

试验项目经费来源

GenieBiome Limited

试验范围

/

目标入组人数

6

实际入组人数

/

第一例入组时间

2025-11-17

试验终止时间

2027-11-16

是否属于一致性

/

入选标准

Inclusion Criteria: •Individuals aged 18 - 60 who is newly diagnosed with stage I, II or III cancer •Planned chemotherapy to be completed within 6 months •Literate and can complete the self-report questionnaires •Able to understand the consent and sign the informed consent form；

排除标准

Exclusion Criteria: •Metastatic cancers with life expectancy <6 months •Pre-existing female-pattern or male-pattern baldness •History of hair transplantation, psoriasis or severe scalp infection •Undergoing or plan to receive scalp cooling •Plan for immunotherapy •Severe cardiac, hepatic, renal, pulmonary and haematic lesions or other life-threatening conditions •Known pregnancy or lactating •Use of antibiotics, probiotics or prebiotics in the last 4 weeks •History of allergy to probiotics or lactose •History of chemotherapy for other conditions；

研究者信息
研究负责人姓名
请登录查看
试验机构

Geniebiome Limited

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Geniebiome Limited的其他临床试验

更多

GenieBiome Limited的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品